Search | Clinical Trials Finder

Conditions: Hydrops Fetalis, Fetal Growth Retardation
Interventions: Tandem MS test for inborn errors of metabolism; Procedure
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 11
States / cities: Phoenix, Arizona • Laguna Hills, California • Long Beach, California + 6 more

Conditions: Obstructive Sleep Apnea, Fetal Growth Restriction, Pregnancy Related
Interventions: S9 VPAP Adapt; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: St Louis, Missouri • Rochester, New York

Conditions: Short Stature, Constitutional Delay of Growth and Development, Dwarfism, Pituitary
Interventions: Growth Hormone Therapy; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 7 Years to 10 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Prematurity; Extreme, Failure to Thrive in Newborn, Growth Retardation, Growth Failure, Infant Nutrition Disorders
Interventions: Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid, Similac Liquid Protein Fortifier, Nestle Microlipid, Medica Nutrition SolCarb, Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification), Similac Liquid Protein Fortifier (Targeted Fortification), Nestle Microlipid (Targeted Fortification), Medica Nutrition SolCarb (Targeted Fortification), Analysis with Miris (AB) Human Milk Analyzer; Dietary Supplement · Other
Lead sponsor: Columbia University; Other
Eligibility: 1 Day to 21 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Constitutional Growth Delay, Nutrition Disorders, Growth Disorders
Interventions: Pediasure, GH; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 7 Years to 10 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Intrauterine Growth Restriction, Villitis, IUGR
Interventions: Comprehensive Doppler Ultrasound of the Placenta, Verasonics Ultrasound scanner (ultra-sensitive Doppler imaging); Diagnostic Test · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Fetal Growth Retardation
Interventions: Ferumoxytol infusion, MRI scan; Drug · Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Fetal Growth Restriction, Fetal Growth Abnormality
Interventions: No intervention; Other
Lead sponsor: Katherine Grantz; NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 2,809 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pre-eclampsia, Intrauterine Growth Retardation
Interventions: Modernized prenatal care; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 35 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pre-Eclampsia, Pre-Term, Intrauterine Growth Restriction, Hypertension in Pregnancy
Interventions: Anti-inflammatory supplement; Dietary Supplement
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Intrauterine Growth Restriction
Interventions: Oxygen; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intrauterine Growth Retardation
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Months to 18 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 5
States / cities: Atlanta, Georgia • Indianapolis, Indiana • New Hyde Park, New York + 2 more

Conditions: Hypoglycemia, Infant, Small for Gestational Age, Premature Birth of Newborn, Fetal Macrosomia, Intrauterine Growth Restriction, Complication of Prematurity, Neonatal Hypoglycemia
Interventions: 40% Dextrose gel; Dietary Supplement
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 0 Hours to 1 Hour
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Insulin-like Growth Factor-1 Deficiency
Interventions: NutropinAq® (Somatropin [rDNA origin]), Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin]); Drug
Lead sponsor: Ipsen; Industry
Eligibility: 5 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Sleep Apnea Syndromes
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,685 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Fetal Growth Restriction (FGR), Placental Insufficiency, Preeclampsia, Still Births, Pregnancy, Pregnancy Complications, Pregnancy Outcomes, Ultrasound
Interventions: ultrafast power Doppler imaging (uPDI) / quantitative ultrasound (QUS); Device
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Hypertensive Disorder of Pregnancy, Pulmonary Arterial Hypertension, Intrauterine Growth Restriction
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post Term Pregnancy, Premature Rupture of Membrane, Fetal Growth Retardation, Oligohydramnios, Gestational Diabetes, High Blood Pressure in Pregnancy
Interventions: Dilapan-S; Device
Lead sponsor: Medicem Technology s.r.o.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Fetal Growth Restriction, USCOM
Interventions: USCOM; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteogenesis Imperfecta
Interventions: Humatrope; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 3 Years to 16 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Intrauterine Growth Retardation
Interventions: selective laser photocoagulation of communicating vessels, Expected Management; Procedure · Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Los Angeles, California • Tampa, Florida

Conditions: Fetal Growth Retardation, Fetal Growth Complications, Placental Insufficiency
Interventions: Physical activity; Other
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Twin; Pregnancy, Affecting Fetus or Newborn, Fetal Growth Retardation, Twin Monochorionic Diamniotic Placenta, Twin Diseases
Interventions: Ultrasound; Diagnostic Test
Lead sponsor: Leiden University Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Reproductive Effects, Pregnancy
Interventions: Not listed
Lead sponsor: Rowan University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Stratford, New Jersey

Search by objective public record fields.

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

Sleep Apnea and Fetal Growth Restriction

Role of Nutrition and Hormones in Boys With Disordered Growth

Targeted Fortification of Donor Breast Milk in Preterm Infants

Nutrients and Hormones: Effects in Boys With Disordered Growth

Predicting Placental Pathologies by Ultrasound Imaging

Placental Lesions in Fetal Growth Restrictions

Fetal 3D Study (Fetal Body Composition and Volumes Study)

A Modernized Approach to Prenatal Care in Low Risk Women

Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes

MRI Assessment of Placental Health

Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

Placental Imaging Techniques

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia

Dilapan-S®: A Multicenter US E-registry

USCOM in Newly Diagnosed FGR Cases

Growth Hormone Therapy in Osteogenesis Imperfecta

Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery

Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

Vitamin D and Pregnancy: Camden Study